Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Dettagli Bibliografici
Autore principale: Shobnam, Sohana
Altri autori: Azam, Faruque
Natura: Tesi
Lingua:English
Pubblicazione: Brac University 2024
Soggetti:
Accesso online:http://hdl.handle.net/10361/24396
id 10361-24396
record_format dspace
spelling 10361-243962024-10-24T21:03:13Z Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer Shobnam, Sohana Azam, Faruque School of Pharmacy, Brac University Phase II trials Breast cancer Efficacy endpoints Progression-free survival Breast Cancer. Breast Cancer--Survival. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. Cataloged from PDF version of thesis. Includes bibliographical references (pages 15-17). Metastatic breast cancer requires more investigation because of its high incidence. Efforts to improve the accessibility, evaluative simplicity, and predictive accuracy of clinical trial endpoints are ongoing. In this paper, we analyzed 410 Phase II clinical trials’ endpoints to assess the efficacy and impact of anticancer agents. We estimated the treatment effects for overall survival and progression-free survival using appropriate statistical methodologies. We found a significant moderate positive correlation between OS and PFS (r = 0.63, 95% CI 0.55–0.71, P < 0.001). Moreover, PFS predicted the OS with a 40% accuracy (R-sq= 0.40). Interestingly, PFS showed significant differences in 1-2-and-3-agent trials, however, this was not reflected in the OS for 2-and-3-agent trials, indicating the need for further validation of the surrogacy of PFS. Nonetheless, PFS is somewhat reliable surrogate of OS in phase II trials of breast cancer and we recommend finding a better surrogate than PFS. Sohana Shobnam B. Pharmacy 2024-10-24T05:01:32Z 2024-10-24T05:01:32Z ©2024 2024-05 Thesis ID 20146042 http://hdl.handle.net/10361/24396 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 17 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Phase II trials
Breast cancer
Efficacy endpoints
Progression-free survival
Breast Cancer.
Breast Cancer--Survival.
spellingShingle Phase II trials
Breast cancer
Efficacy endpoints
Progression-free survival
Breast Cancer.
Breast Cancer--Survival.
Shobnam, Sohana
Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
author2 Azam, Faruque
author_facet Azam, Faruque
Shobnam, Sohana
format Thesis
author Shobnam, Sohana
author_sort Shobnam, Sohana
title Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
title_short Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
title_full Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
title_fullStr Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
title_full_unstemmed Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
title_sort pooled analysis of progression-free survival and overall survival in phase ii clinical trials of breast cancer
publisher Brac University
publishDate 2024
url http://hdl.handle.net/10361/24396
work_keys_str_mv AT shobnamsohana pooledanalysisofprogressionfreesurvivalandoverallsurvivalinphaseiiclinicaltrialsofbreastcancer
_version_ 1814308580025696256